Bill Sponsor
Senate Bill 2465
115th Congress(2017-2018)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Became Law
Became Law
Became Public Law 115-327 on Dec 18, 2018
Overview
Text
Sponsor
Introduced
Feb 28, 2018
Latest Action
Dec 18, 2018
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2465
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
South Carolina
Democrat
Alabama
Republican
Louisiana
Democrat
Massachusetts
Democrat
New Jersey
Senate Votes (1)
House Votes (1)
checkPassed on October 11, 2018
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(consideration: CR S6880; text: CR S6880)
Summary

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2018

This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to award grants to government, educational, and nonprofit entities for the purpose of supporting data collection and public health activities regarding sickle cell disease.

Additionally, the bill reauthorizes through FY2022 and revises the sickle cell disease grant program for federally-qualified health centers, nonprofit hospitals or clinics, and university health centers.

Text (4)
October 11, 2018
August 15, 2018
February 28, 2018
Actions (19)
12/18/2018
Became Public Law No: 115-327.
12/18/2018
Signed by President.
12/13/2018
Presented to President.
12/11/2018
Motion to reconsider laid on the table Agreed to without objection.
12/11/2018
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H10052-10053)
12/11/2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H10052-10053)
12/11/2018
DEBATE - The House proceeded with forty minutes of debate on S. 2465.
12/11/2018
Considered under suspension of the rules. (consideration: CR H10043-10052)
12/11/2018
Mr. Burgess moved to suspend the rules and pass the bill.
10/16/2018
Held at the desk.
10/16/2018
Received in the House.
10/12/2018
Message on Senate action sent to the House.
10/11/2018
Passed Senate with an amendment by Voice Vote. (consideration: CR S6880; text: CR S6880)
10/11/2018
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(consideration: CR S6880; text: CR S6880)
08/15/2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 553.
08/15/2018
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
07/25/2018
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
02/28/2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1288)
02/28/2018
Introduced in Senate
Public Record
Record Updated
Mar 22, 2023 7:51:01 PM